GreenLight Biosciences Holdings
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of GreenLight Biosciences Holdings generated cash of -$136,731,000, which is less than the previous year. Cash used in financing activities reached the amount of $200,851,000 last year. Net change in cash is therefore $37,610,000.
Cash Flow
| 2019 | -25.63M | -1.89M | 13.31M |
|---|---|---|---|
| 2020 | -46.59M | -10.04M | 125.84M |
| 2021 | -91.83M | -15.03M | 43.53M |
| 2022 | -136.73M | -26.51M | 200.85M |
GRNA Cash Flow Statement (2019 – 2022)
| 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|
Cash at beginning of period | 31.80M | 95.14M | 25.94M | 40.16M |
Operating activities | ||||
Net income | -167.05M | -112.31M | -53.25M | -28.64M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||
Depreciation and amortization | 8.07M | 5.77M | 1.75M | 688K |
Stock-based compensation expense | 8.83M | 1.99M | 659K | 430K |
| Deferred income tax benefit | 8.83M | 1.99M | 659K | 430K |
| Changes in operating assets and liabilities: | ||||
Accounts receivable, net | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 |
Accounts payable | -6.61M | 3.69M | 1.17M | 506K |
Cash generated by operating activities | -136.73M | -91.83M | -46.59M | -25.63M |
Investing activities | ||||
Purchases Of Investments | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -26.54M | -15.14M | -10.04M | -1.89M |
Acquisitions Net | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -26.51M | -15.03M | -10.04M | -1.89M |
Financing activities | ||||
Common Stock Issued | 106.02M | 206.75M | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | -2.42M | -632K | 0 |
Cash used in financing activities | 200.85M | 43.53M | 125.84M | 13.31M |
Net Change In Cash | 37.61M | -63.34M | 69.20M | -14.21M |
Cash at end of period | 69.41M | 31.80M | 95.14M | 25.94M |
| Data source | Data source | Data source |